Clinical Trial Update: An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 open study evaluating sulforaphane-rich broccoli sprout extract in patients with schizophrenia has completed at Chiba University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Sulforaphane-rich broccoli sprout extract (sulforaphane-rich broccoli sprout extract)

Snippet

Sponsor: Chiba University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED